Integral Diagnostics Ltd
ASX:IDX
Balance Sheet
Balance Sheet Decomposition
Integral Diagnostics Ltd
Current Assets | 65.7m |
Cash & Short-Term Investments | 18m |
Receivables | 35.6m |
Other Current Assets | 12.1m |
Non-Current Assets | 680.1m |
Long-Term Investments | 5k |
PP&E | 276m |
Intangibles | 404.1m |
Current Liabilities | 86.1m |
Accounts Payable | 28.3m |
Other Current Liabilities | 57.8m |
Non-Current Liabilities | 359.4m |
Long-Term Debt | 343.6m |
Other Non-Current Liabilities | 15.7m |
Balance Sheet
Integral Diagnostics Ltd
Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
6
|
10
|
24
|
24
|
21
|
21
|
58
|
62
|
123
|
34
|
|
Cash |
6
|
10
|
24
|
24
|
21
|
21
|
58
|
62
|
123
|
34
|
|
Short-Term Investments |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
4
|
5
|
6
|
6
|
6
|
10
|
12
|
18
|
24
|
24
|
|
Accounts Receivables |
4
|
5
|
6
|
6
|
6
|
10
|
12
|
18
|
21
|
24
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
4
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
Other Current Assets |
1
|
1
|
2
|
2
|
4
|
2
|
5
|
1
|
5
|
3
|
|
Total Current Assets |
12
|
16
|
32
|
33
|
30
|
34
|
76
|
82
|
154
|
63
|
|
PP&E Net |
18
|
38
|
47
|
51
|
54
|
71
|
190
|
211
|
231
|
282
|
|
PP&E Gross |
18
|
38
|
47
|
51
|
0
|
71
|
190
|
211
|
231
|
282
|
|
Accumulated Depreciation |
22
|
21
|
28
|
33
|
0
|
48
|
61
|
76
|
95
|
103
|
|
Intangible Assets |
2
|
9
|
8
|
8
|
7
|
18
|
27
|
29
|
28
|
30
|
|
Goodwill |
11
|
90
|
90
|
96
|
96
|
184
|
280
|
316
|
352
|
444
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
1
|
3
|
5
|
3
|
8
|
8
|
14
|
16
|
17
|
19
|
|
Other Assets |
11
|
90
|
90
|
96
|
96
|
184
|
280
|
316
|
352
|
444
|
|
Total Assets |
44
N/A
|
156
+254%
|
181
+16%
|
190
+5%
|
196
+3%
|
315
+61%
|
587
+87%
|
655
+12%
|
783
+20%
|
839
+7%
|
|
Liabilities | |||||||||||
Accounts Payable |
4
|
3
|
4
|
3
|
12
|
5
|
5
|
5
|
9
|
10
|
|
Accrued Liabilities |
3
|
16
|
16
|
5
|
0
|
22
|
30
|
36
|
37
|
48
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
5
|
14
|
7
|
11
|
13
|
9
|
23
|
17
|
17
|
17
|
|
Other Current Liabilities |
8
|
6
|
1
|
11
|
11
|
2
|
19
|
21
|
17
|
8
|
|
Total Current Liabilities |
21
|
39
|
28
|
31
|
36
|
38
|
76
|
78
|
80
|
83
|
|
Long-Term Debt |
13
|
69
|
62
|
61
|
53
|
130
|
255
|
291
|
324
|
348
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
5
|
8
|
12
|
14
|
14
|
18
|
|
Minority Interest |
2
|
7
|
8
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
2
|
7
|
8
|
8
|
9
|
11
|
16
|
17
|
18
|
17
|
|
Total Liabilities |
38
N/A
|
107
+185%
|
89
-17%
|
92
+3%
|
102
+11%
|
187
+84%
|
359
+91%
|
400
+12%
|
436
+9%
|
466
+7%
|
|
Equity | |||||||||||
Common Stock |
3
|
51
|
83
|
84
|
83
|
110
|
207
|
219
|
323
|
333
|
|
Retained Earnings |
4
|
2
|
9
|
14
|
10
|
26
|
30
|
45
|
36
|
50
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
8
|
9
|
9
|
11
|
10
|
|
Total Equity |
6
N/A
|
49
+660%
|
92
+89%
|
98
+7%
|
93
-5%
|
127
+36%
|
228
+79%
|
255
+12%
|
347
+36%
|
373
+7%
|
|
Total Liabilities & Equity |
44
N/A
|
156
+254%
|
181
+16%
|
190
+5%
|
196
+3%
|
315
+61%
|
587
+87%
|
655
+12%
|
783
+20%
|
839
+7%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
147
|
147
|
149
|
150
|
150
|
162
|
197
|
201
|
229
|
233
|